cetirizine has been researched along with Chronic Illness in 74 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Combination of cetirizine with ranitidine was not more effective than cetirizine alone in chronic urticaria." | 9.20 | Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study. ( Bonilla-Lopez, S; Guevara-Gutierrez, E; Hernández-Arana, S; Tlacuilo-Parra, A, 2015) |
| "Cetirizine is commonly used in the treatment of urticaria." | 9.19 | Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial. ( Dakhale, GN; Hiware, SK; Mahatme, MS; Mishra, DB; Mukhi, JI; Salve, AM; Shinde, AT, 2014) |
| "Levocetirizine led to a significantly greater decrease in pruritus severity than desloratadine over the first treatment week; mean pruritus severity scores of 1." | 9.14 | Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. ( Finlay, AY; Guillet, G; Hauptmann, P; Jian, AM; Kapp, A; Maurer, M; Potter, PC, 2009) |
| "Bilastine is a novel nonsedative H(1)-receptor antagonist, which may be used for the symptomatic treatment of chronic idiopathic urticaria (CU)." | 9.14 | Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study. ( Antépara, I; Bogacka, E; Jáuregui, I; Medina, I; Oanta, A; Uhl, P; Valiente, R; Wesel, F; Zuberbier, T, 2010) |
| "Eighty tertiary referral patients with chronic urticaria (age range, 19-67 years) were randomized for double-blind treatment with levocetirizine or desloratadine (40/40)." | 9.14 | The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. ( Church, DS; Church, MK; Dimitrov, V; Kraeva, S; Kralimarkova, T; Lazarova, C; Popov, TA; Popova, D; Staevska, M, 2010) |
| "A 4-week randomized, double-blind safety and efficacy study was conducted to compare the safety and efficacy of cetirizine, doxepine, and hydroxyzine 5 in the treatment of chronic pruritus due to sulfur mustard." | 9.12 | Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. ( Davoudi, SM; Keshavarz, S; Sadr, B; Shohrati, M; Tajik, A, 2007) |
| "To determine whether levocetirizine is efficacious in the treatment of chronic idiopathic urticaria." | 9.12 | Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. ( Barra, L; Colanardi, MC; Ferrannini, A; Nettis, E; Tursi, A; Vacca, A, 2006) |
| "A double-blinded, placebo-controlled trial comparing cetirizine 10 mg daily in combination with zafirlukast 20 mg twice a day versus cetirizine 10 mg daily and placebo was conducted to determine whether subjects with chronic urticaria benefit from add-on therapy with a leukotriene-modifying agent." | 9.11 | The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. ( Bagenstose, SE; Bernstein, JA; Levin, L, 2004) |
| "The results of the present study suggest that cetirizine may represent an effective and safe pharmacologic therapy for chronic urticaria in preschool children." | 9.09 | Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. ( Barberio, G; Corrias, A; Grimaldi, I; La Rosa, M; Leonardi, S; Marchese, G; Oggiano, N, 2001) |
| "The results of this comparative study demonstrate that montelukast orally administered once a day is very effective for the treatment of cutaneous symptoms in patients with chronic urticaria due to food additives and/or ASA." | 9.09 | Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. ( Corrocher, R; Di Lorenzo, G; Pacor, ML, 2001) |
| "In this study co-administration of hydroxyzine with cimetidine resulted in significantly increased serum hydroxyzine concentrations and increased wheal and flare suppression, thus confirming the rationale for a trial of concomitant administration of these medications in some patients with chronic urticaria unresponsive to treatment with an H1-antagonist alone." | 9.08 | Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. ( Simons, FE; Simons, KJ; Sussman, GL, 1995) |
| "Cetirizine 10 mg once daily was equivalent to hydroxyzine 25 mg tid in controlling the symptoms of patients with chronic urticaria, as assessed by patient and investigator evaluations." | 9.08 | Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. ( Breneman, DL, 1996) |
| "Our randomised study in parallel groups, double-blind double placebo, has compared the efficacy, onset of action and safety of terfenadine and cetirizine in chronic idiopathic urticaria." | 9.07 | [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria]. ( Bloom, M; Danglas, P; Hantzperg, M; Lambert, D, 1993) |
| "The efficacy of cetirizine dihydrochloride, a new H1-antagonist claimed to have minimal sedative property was evaluated in 28 patients with chronic idiopathic urticaria." | 9.07 | Cetirizine vs placebo in chronic idiopathic urticaria--a double blind randomised cross-over study. ( Goh, CL; Lim, J; Wong, WK, 1991) |
| "In a 20-d, double-blind, randomized, parallel study, the efficacy of cetirizine and terfenadine was compared in 30 patients with chronic idiopathic urticaria." | 9.07 | A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria. ( Andri, G; Andri, L; Betteli, C; Givanni, S; Lombardi, C; Mezzelani, P; Senna, GE, 1993) |
| "Clinical trials of a new histamine H1-blocker of the III generation zyrtec (cetirizine) manufactured in Belgium (UCB) demonstrated its high efficacy in pollenosis and chronic idiopathic urticaria." | 9.07 | [The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis]. ( Androsov, VN; Belostotskaia, OI; Il'ina, NI, 1994) |
| "Only recently available on the US market, levocetirizine has emerged as an effective new option in the treatment of chronic idiopathic urticaria (CIU)." | 8.85 | Levocetirizine for chronic idiopathic urticaria: a review. ( Ducharme, EE; Weinberg, JM, 2009) |
| "H1-receptor inhibiting drugs, namely loratadine and cetirizine, were frequently used in treatment of chronic urticaria." | 7.80 | Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria. ( Başak, PY; Buyukbayram, HI; Erturan, I; Kazanoglu, OO; Vural, H, 2014) |
| "We investigated the suitability of cetirizine HCl (cetirizine) for the initial treatment of chronic urticaria." | 7.74 | Evaluation of cetirizine hydrochloride-based therapeutic strategy for chronic urticaria. ( Ando, K; Azumi, T; Hirai, S; Kamiya, S; Kondo, T; Masaki, S; Mori, T; Nitta, Y; Sugiura, K; Suzuki, T; Tomita, Y; Usuda, T; Yokoi, T, 2008) |
| "Treating chronic idiopathic urticaria with levocetirizine is a dominant strategy for society since it is more effective (in terms of pruritus-free days gained) and less costly than placebo." | 7.73 | Cost effectiveness of levocetirizine in chronic idiopathic urticaria : a pooled analysis of two randomised controlled trials. ( Demarteau, N; Kapp, A, 2006) |
| "To determine if 6 weeks of therapy with levocetirizine 5 mg once daily would also induce any decrease in serum levels of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, endothelial leucocyte adhesion molecule-1 (ELAM-1) or P-selectin in subjects with CU and chronic autoimmune urticaria." | 7.73 | Cellular adhesion molecules in chronic urticaria: modulation of serum levels occurs during levocetirizine treatment. ( Caproni, M; Del Bianco, E; Fabbri, P; Giomi, B; Torchia, D; Volpi, W, 2006) |
| "By using capsaicin cough sensitivity as the basis for grouping the study subjects, we divided the patients into 2 groups: an increased cough sensitivity group (ICS, C5 <32 mumol/L) and a normal cough sensitivity (NCS) group." | 7.72 | Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin. ( Cho, YS; Lee, CK; Moon, HB; Park, SY; Yoo, B, 2003) |
| "The paradoxical acute exacerbation of pre-existing chronic idiopathic urticaria accompanied by intense generalized pruritus, facial oedema, and dyspnoea in a 36-year-old-woman 3-4 h after a single oral dose of 10 mg cetirizine (Zyrtec tablets), suggested the presence of an underlying intolerance reaction." | 7.71 | Urticarial intolerance reaction to cetirizine. ( Damveld, B; Marsch, WC; Schröter, S, 2002) |
| "The effects of oral administration of the antihistamine cetirizine on the weal and flare caused by intradermal injection of platelet activating factor (PAF-acether), kallikrein, histamine and the patient's own serum were investigated in 10 patients with chronic urticaria." | 7.68 | Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria. ( Juhlin, L; Rihoux, JP, 1990) |
| "Bilastine is a recently introduced, non-sedative H1-antihistamine for its treatment." | 6.94 | Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial. ( Biswas, D; Chowdhury, SN; Das, A; Ghosh, S; Podder, I; Sengupta, S, 2020) |
| "Levocetirizine was found to be more efficacious than rupatadine in CIU patients, but both drugs caused mild sedation." | 6.80 | Levocetirizine and rupatadine in chronic idiopathic urticaria. ( Badyal, DK; Johnson, M; Kwatra, G; Thomas, EA, 2015) |
| "Olopatadine is a safe and more effective alternative to levocetirizine in the treatment of CU." | 6.78 | Olopatadine versus levocetirizine in chronic urticaria: an observer-blind, randomized, controlled trial of effectiveness and safety. ( Bagchi, C; Chaudhuri, A; Das, NK; Hazra, A; Islam, CN; Sil, A; Tripathi, SK, 2013) |
| "Chronic Idiopathic Urticaria is difficult to treat due to its persistent debilitating symptoms." | 6.76 | Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety. ( Ahmed, I; Goud, P; Jaida, J; Maiti, R; Palani, A; Raghavendra, BN, 2011) |
| "Chronic urticaria was related to the immune unbalance of body." | 6.73 | [Effect of integrative Chinese and Western medicine in treating chronic urticaria and its impact on interleukin-10 and interleukin-8 in peripheral blood]. ( Fang, ZD; Jin, CY; Wang, DL, 2008) |
| "Levocetirizine is an antihistamine from the latest generation approved for CIU." | 6.72 | Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. ( Kapp, A; Pichler, WJ, 2006) |
| "Cetirizine is a new H1 antagonist with potent inhibitory action against the infiltration of eosinophils into involved tissue, thereby affecting the late-phase reaction." | 6.38 | Cetirizine: a new H1 antagonist with antieosinophilic activity in chronic urticaria. ( Townley, RG, 1991) |
| "Recently, several authors have suggested an off-label increase of antihistamine dosage should be given to patients with chronic urticaria (CU) not responding to the usual, recommended doses, in order to gain better control of the disease." | 5.34 | Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. ( Asero, R, 2007) |
| "Combination of cetirizine with ranitidine was not more effective than cetirizine alone in chronic urticaria." | 5.20 | Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study. ( Bonilla-Lopez, S; Guevara-Gutierrez, E; Hernández-Arana, S; Tlacuilo-Parra, A, 2015) |
| "Cetirizine is commonly used in the treatment of urticaria." | 5.19 | Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial. ( Dakhale, GN; Hiware, SK; Mahatme, MS; Mishra, DB; Mukhi, JI; Salve, AM; Shinde, AT, 2014) |
| "Many physicians believe that the most effective way to treat chronic urticaria is to take a nonsedating second-generation H1 -antihistamine in the morning and a sedating first-generation H1 -antihistamine, usually hydroxyzine, at night to enhance sleep." | 5.19 | Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. ( Church, MK; Dimitrov, V; Gugutkova, M; Kralimarkova, T; Lazarova, C; Popov, TA; Staevska, M; Zuberbier, T, 2014) |
| "Levocetirizine led to a significantly greater decrease in pruritus severity than desloratadine over the first treatment week; mean pruritus severity scores of 1." | 5.14 | Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. ( Finlay, AY; Guillet, G; Hauptmann, P; Jian, AM; Kapp, A; Maurer, M; Potter, PC, 2009) |
| "Bilastine is a novel nonsedative H(1)-receptor antagonist, which may be used for the symptomatic treatment of chronic idiopathic urticaria (CU)." | 5.14 | Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study. ( Antépara, I; Bogacka, E; Jáuregui, I; Medina, I; Oanta, A; Uhl, P; Valiente, R; Wesel, F; Zuberbier, T, 2010) |
| "Eighty tertiary referral patients with chronic urticaria (age range, 19-67 years) were randomized for double-blind treatment with levocetirizine or desloratadine (40/40)." | 5.14 | The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. ( Church, DS; Church, MK; Dimitrov, V; Kraeva, S; Kralimarkova, T; Lazarova, C; Popov, TA; Popova, D; Staevska, M, 2010) |
| "To determine whether levocetirizine is efficacious in the treatment of chronic idiopathic urticaria." | 5.12 | Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. ( Barra, L; Colanardi, MC; Ferrannini, A; Nettis, E; Tursi, A; Vacca, A, 2006) |
| "A 4-week randomized, double-blind safety and efficacy study was conducted to compare the safety and efficacy of cetirizine, doxepine, and hydroxyzine 5 in the treatment of chronic pruritus due to sulfur mustard." | 5.12 | Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. ( Davoudi, SM; Keshavarz, S; Sadr, B; Shohrati, M; Tajik, A, 2007) |
| "A double-blinded, placebo-controlled trial comparing cetirizine 10 mg daily in combination with zafirlukast 20 mg twice a day versus cetirizine 10 mg daily and placebo was conducted to determine whether subjects with chronic urticaria benefit from add-on therapy with a leukotriene-modifying agent." | 5.11 | The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. ( Bagenstose, SE; Bernstein, JA; Levin, L, 2004) |
| "The results of the present study suggest that cetirizine may represent an effective and safe pharmacologic therapy for chronic urticaria in preschool children." | 5.09 | Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. ( Barberio, G; Corrias, A; Grimaldi, I; La Rosa, M; Leonardi, S; Marchese, G; Oggiano, N, 2001) |
| "The results of this comparative study demonstrate that montelukast orally administered once a day is very effective for the treatment of cutaneous symptoms in patients with chronic urticaria due to food additives and/or ASA." | 5.09 | Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. ( Corrocher, R; Di Lorenzo, G; Pacor, ML, 2001) |
| "In this study co-administration of hydroxyzine with cimetidine resulted in significantly increased serum hydroxyzine concentrations and increased wheal and flare suppression, thus confirming the rationale for a trial of concomitant administration of these medications in some patients with chronic urticaria unresponsive to treatment with an H1-antagonist alone." | 5.08 | Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. ( Simons, FE; Simons, KJ; Sussman, GL, 1995) |
| "Cetirizine 10 mg once daily was equivalent to hydroxyzine 25 mg tid in controlling the symptoms of patients with chronic urticaria, as assessed by patient and investigator evaluations." | 5.08 | Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. ( Breneman, DL, 1996) |
| "Clinical trials of a new histamine H1-blocker of the III generation zyrtec (cetirizine) manufactured in Belgium (UCB) demonstrated its high efficacy in pollenosis and chronic idiopathic urticaria." | 5.07 | [The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis]. ( Androsov, VN; Belostotskaia, OI; Il'ina, NI, 1994) |
| "In a 20-d, double-blind, randomized, parallel study, the efficacy of cetirizine and terfenadine was compared in 30 patients with chronic idiopathic urticaria." | 5.07 | A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria. ( Andri, G; Andri, L; Betteli, C; Givanni, S; Lombardi, C; Mezzelani, P; Senna, GE, 1993) |
| "Our randomised study in parallel groups, double-blind double placebo, has compared the efficacy, onset of action and safety of terfenadine and cetirizine in chronic idiopathic urticaria." | 5.07 | [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria]. ( Bloom, M; Danglas, P; Hantzperg, M; Lambert, D, 1993) |
| "The efficacy of cetirizine dihydrochloride, a new H1-antagonist claimed to have minimal sedative property was evaluated in 28 patients with chronic idiopathic urticaria." | 5.07 | Cetirizine vs placebo in chronic idiopathic urticaria--a double blind randomised cross-over study. ( Goh, CL; Lim, J; Wong, WK, 1991) |
| "Only recently available on the US market, levocetirizine has emerged as an effective new option in the treatment of chronic idiopathic urticaria (CIU)." | 4.85 | Levocetirizine for chronic idiopathic urticaria: a review. ( Ducharme, EE; Weinberg, JM, 2009) |
| "H1-receptor inhibiting drugs, namely loratadine and cetirizine, were frequently used in treatment of chronic urticaria." | 3.80 | Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria. ( Başak, PY; Buyukbayram, HI; Erturan, I; Kazanoglu, OO; Vural, H, 2014) |
| " A 23-month-old male with a history of chronic otitis media was prescribed cetirizine 2." | 3.76 | Use of cetirizine in a 23-month-old male causes insomnia. ( Jones, CE; Jones, MC, 2010) |
| "We investigated the suitability of cetirizine HCl (cetirizine) for the initial treatment of chronic urticaria." | 3.74 | Evaluation of cetirizine hydrochloride-based therapeutic strategy for chronic urticaria. ( Ando, K; Azumi, T; Hirai, S; Kamiya, S; Kondo, T; Masaki, S; Mori, T; Nitta, Y; Sugiura, K; Suzuki, T; Tomita, Y; Usuda, T; Yokoi, T, 2008) |
| "Treating chronic idiopathic urticaria with levocetirizine is a dominant strategy for society since it is more effective (in terms of pruritus-free days gained) and less costly than placebo." | 3.73 | Cost effectiveness of levocetirizine in chronic idiopathic urticaria : a pooled analysis of two randomised controlled trials. ( Demarteau, N; Kapp, A, 2006) |
| "To determine if 6 weeks of therapy with levocetirizine 5 mg once daily would also induce any decrease in serum levels of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, endothelial leucocyte adhesion molecule-1 (ELAM-1) or P-selectin in subjects with CU and chronic autoimmune urticaria." | 3.73 | Cellular adhesion molecules in chronic urticaria: modulation of serum levels occurs during levocetirizine treatment. ( Caproni, M; Del Bianco, E; Fabbri, P; Giomi, B; Torchia, D; Volpi, W, 2006) |
| "By using capsaicin cough sensitivity as the basis for grouping the study subjects, we divided the patients into 2 groups: an increased cough sensitivity group (ICS, C5 <32 mumol/L) and a normal cough sensitivity (NCS) group." | 3.72 | Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin. ( Cho, YS; Lee, CK; Moon, HB; Park, SY; Yoo, B, 2003) |
| "The paradoxical acute exacerbation of pre-existing chronic idiopathic urticaria accompanied by intense generalized pruritus, facial oedema, and dyspnoea in a 36-year-old-woman 3-4 h after a single oral dose of 10 mg cetirizine (Zyrtec tablets), suggested the presence of an underlying intolerance reaction." | 3.71 | Urticarial intolerance reaction to cetirizine. ( Damveld, B; Marsch, WC; Schröter, S, 2002) |
| "The effects of oral administration of the antihistamine cetirizine on the weal and flare caused by intradermal injection of platelet activating factor (PAF-acether), kallikrein, histamine and the patient's own serum were investigated in 10 patients with chronic urticaria." | 3.68 | Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria. ( Juhlin, L; Rihoux, JP, 1990) |
| "Bilastine is a recently introduced, non-sedative H1-antihistamine for its treatment." | 2.94 | Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial. ( Biswas, D; Chowdhury, SN; Das, A; Ghosh, S; Podder, I; Sengupta, S, 2020) |
| "Levocetirizine was found to be more efficacious than rupatadine in CIU patients, but both drugs caused mild sedation." | 2.80 | Levocetirizine and rupatadine in chronic idiopathic urticaria. ( Badyal, DK; Johnson, M; Kwatra, G; Thomas, EA, 2015) |
| "Olopatadine is a safe and more effective alternative to levocetirizine in the treatment of CU." | 2.78 | Olopatadine versus levocetirizine in chronic urticaria: an observer-blind, randomized, controlled trial of effectiveness and safety. ( Bagchi, C; Chaudhuri, A; Das, NK; Hazra, A; Islam, CN; Sil, A; Tripathi, SK, 2013) |
| "Chronic Idiopathic Urticaria is difficult to treat due to its persistent debilitating symptoms." | 2.76 | Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety. ( Ahmed, I; Goud, P; Jaida, J; Maiti, R; Palani, A; Raghavendra, BN, 2011) |
| " Secondary end-points were the rate of control of chronic cough at each step of therapy, the duration of treatment required, changes in cough symptom score, health-related quality of life and possible adverse effects." | 2.75 | Efficacy and safety of modified sequential three-step empirical therapy for chronic cough. ( Li, X; Liang, S; Liu, B; Lü, H; Qiu, Z; Wang, L; Wang, Y; Wei, W; Yu, L, 2010) |
| "Chronic urticaria was related to the immune unbalance of body." | 2.73 | [Effect of integrative Chinese and Western medicine in treating chronic urticaria and its impact on interleukin-10 and interleukin-8 in peripheral blood]. ( Fang, ZD; Jin, CY; Wang, DL, 2008) |
| "Levocetirizine is an antihistamine from the latest generation approved for CIU." | 2.72 | Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. ( Kapp, A; Pichler, WJ, 2006) |
| "Levocetirizine has several pharmacokinetic properties that are desirable for an antihistamine providing a combination of both potency and safety." | 2.47 | Pharmacokinetic evaluation of levocetirizine. ( Ferrer, M, 2011) |
| "Cetirizine is a new H1 antagonist with potent inhibitory action against the infiltration of eosinophils into involved tissue, thereby affecting the late-phase reaction." | 2.38 | Cetirizine: a new H1 antagonist with antieosinophilic activity in chronic urticaria. ( Townley, RG, 1991) |
| " The first-generation H(1)-antihistamines are associated with marked adverse effects such as sedation, sleepiness/drowsiness as well as difficulties in learning and cognitive processing; thus, they are recommended for limited or discontinued use in children with AR or CIU." | 1.37 | Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease. ( Kurzawa, R; Pampura, AN; Papadopoulos, NG; Spičák, V, 2011) |
| "Recently, several authors have suggested an off-label increase of antihistamine dosage should be given to patients with chronic urticaria (CU) not responding to the usual, recommended doses, in order to gain better control of the disease." | 1.34 | Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. ( Asero, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.35) | 18.7374 |
| 1990's | 19 (25.68) | 18.2507 |
| 2000's | 28 (37.84) | 29.6817 |
| 2010's | 24 (32.43) | 24.3611 |
| 2020's | 2 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Podder, I | 1 |
| Das, A | 1 |
| Ghosh, S | 1 |
| Biswas, D | 1 |
| Sengupta, S | 1 |
| Chowdhury, SN | 1 |
| Shah, B | 1 |
| De, A | 1 |
| Sarda, A | 1 |
| Kochhar, AM | 1 |
| Dhoot, D | 1 |
| Deshmukh, G | 1 |
| Barkate, H | 1 |
| Kolkhir, P | 1 |
| Pogorelov, D | 1 |
| Olisova, O | 1 |
| Iweala, OI | 1 |
| Copenhaver, C | 1 |
| Wu, EY | 1 |
| Moran, TP | 1 |
| Yan, M | 1 |
| Ye, F | 1 |
| Zhang, Y | 1 |
| Cai, X | 1 |
| Fu, Y | 1 |
| Yang, X | 1 |
| Dakhale, GN | 1 |
| Shinde, AT | 1 |
| Mahatme, MS | 1 |
| Hiware, SK | 1 |
| Mishra, DB | 1 |
| Mukhi, JI | 1 |
| Salve, AM | 1 |
| Staevska, M | 2 |
| Gugutkova, M | 1 |
| Lazarova, C | 2 |
| Kralimarkova, T | 2 |
| Dimitrov, V | 2 |
| Zuberbier, T | 2 |
| Church, MK | 2 |
| Popov, TA | 2 |
| Rorie, A | 1 |
| Goldner, WS | 1 |
| Lyden, E | 1 |
| Poole, JA | 1 |
| Başak, PY | 1 |
| Vural, H | 1 |
| Kazanoglu, OO | 1 |
| Erturan, I | 1 |
| Buyukbayram, HI | 1 |
| Johnson, M | 1 |
| Kwatra, G | 1 |
| Badyal, DK | 1 |
| Thomas, EA | 1 |
| Guevara-Gutierrez, E | 1 |
| Bonilla-Lopez, S | 1 |
| Hernández-Arana, S | 1 |
| Tlacuilo-Parra, A | 1 |
| Hsiao, YH | 1 |
| Chen, C | 1 |
| Willemse, T | 1 |
| Sharma, VK | 1 |
| Gupta, V | 1 |
| Pathak, M | 1 |
| Ramam, M | 1 |
| Jin, CY | 1 |
| Wang, DL | 1 |
| Fang, ZD | 1 |
| Sugiura, K | 1 |
| Hirai, S | 1 |
| Suzuki, T | 1 |
| Usuda, T | 1 |
| Kondo, T | 1 |
| Azumi, T | 1 |
| Masaki, S | 1 |
| Yokoi, T | 1 |
| Nitta, Y | 1 |
| Kamiya, S | 1 |
| Ando, K | 1 |
| Mori, T | 1 |
| Tomita, Y | 1 |
| Ciebiada, M | 1 |
| Ciebiada, MG | 1 |
| Kmiecik, T | 1 |
| DuBuske, LM | 1 |
| Gorski, P | 1 |
| Potter, PC | 1 |
| Kapp, A | 3 |
| Maurer, M | 1 |
| Guillet, G | 1 |
| Jian, AM | 1 |
| Hauptmann, P | 1 |
| Finlay, AY | 1 |
| Wan, KS | 1 |
| Ducharme, EE | 1 |
| Weinberg, JM | 1 |
| Oanta, A | 1 |
| Bogacka, E | 1 |
| Medina, I | 1 |
| Wesel, F | 1 |
| Uhl, P | 1 |
| Antépara, I | 1 |
| Jáuregui, I | 1 |
| Valiente, R | 1 |
| Asero, R | 2 |
| Tedeschi, A | 1 |
| Cugno, M | 1 |
| Kraeva, S | 1 |
| Popova, D | 1 |
| Church, DS | 1 |
| Jones, MC | 1 |
| Jones, CE | 1 |
| Wei, W | 1 |
| Yu, L | 1 |
| Wang, Y | 1 |
| Li, X | 1 |
| Qiu, Z | 2 |
| Wang, L | 1 |
| Liu, B | 1 |
| Liang, S | 1 |
| Lü, H | 1 |
| Long, JW | 1 |
| Wang, YY | 1 |
| Pi, XM | 1 |
| Tu, YT | 1 |
| Hong, JB | 2 |
| Lee, HC | 2 |
| Hu, FC | 1 |
| Chu, CY | 2 |
| Pampura, AN | 1 |
| Papadopoulos, NG | 1 |
| Spičák, V | 1 |
| Kurzawa, R | 1 |
| Zhong, J | 1 |
| Xian, D | 1 |
| Xu, Y | 1 |
| Liu, J | 1 |
| Ferrer, M | 1 |
| Maiti, R | 1 |
| Jaida, J | 1 |
| Raghavendra, BN | 1 |
| Goud, P | 1 |
| Ahmed, I | 1 |
| Palani, A | 1 |
| Sil, A | 1 |
| Tripathi, SK | 1 |
| Chaudhuri, A | 1 |
| Das, NK | 1 |
| Hazra, A | 1 |
| Bagchi, C | 1 |
| Islam, CN | 1 |
| Scheindlin, S | 1 |
| Ohtani, T | 1 |
| Aiba, S | 1 |
| Mizuashi, M | 1 |
| Kawamoto, Y | 1 |
| Tagami, H | 1 |
| Cho, YS | 1 |
| Park, SY | 1 |
| Lee, CK | 1 |
| Yoo, B | 1 |
| Moon, HB | 1 |
| Bagenstose, SE | 1 |
| Levin, L | 1 |
| Bernstein, JA | 1 |
| Bloebaum, RM | 1 |
| Grant, JA | 1 |
| Nettis, E | 1 |
| Colanardi, MC | 1 |
| Barra, L | 1 |
| Ferrannini, A | 1 |
| Vacca, A | 1 |
| Tursi, A | 1 |
| Jakate, S | 1 |
| Demeo, M | 1 |
| John, R | 1 |
| Tobin, M | 1 |
| Keshavarzian, A | 1 |
| Pichler, WJ | 2 |
| Caproni, M | 1 |
| Volpi, W | 1 |
| Giomi, B | 1 |
| Torchia, D | 1 |
| Del Bianco, E | 1 |
| Fabbri, P | 1 |
| Demarteau, N | 1 |
| Garg, G | 1 |
| Thami, GP | 1 |
| Monroe, JR | 1 |
| Young, D | 1 |
| Kameyoshi, Y | 1 |
| Tanaka, T | 1 |
| Mihara, S | 1 |
| Takahagi, S | 1 |
| Niimi, N | 1 |
| Hide, M | 1 |
| Shohrati, M | 1 |
| Davoudi, SM | 1 |
| Keshavarz, S | 1 |
| Sadr, B | 1 |
| Tajik, A | 1 |
| Engin, B | 1 |
| Ozdemir, M | 1 |
| Balevi, A | 1 |
| Mevlitoğlu, I | 1 |
| Broide, D | 1 |
| Simons, FE | 1 |
| Sussman, GL | 1 |
| Simons, KJ | 1 |
| Androsov, VN | 1 |
| Belostotskaia, OI | 1 |
| Il'ina, NI | 1 |
| Lambert, D | 1 |
| Hantzperg, M | 1 |
| Danglas, P | 1 |
| Bloom, M | 1 |
| Andri, L | 1 |
| Senna, GE | 1 |
| Betteli, C | 1 |
| Givanni, S | 1 |
| Andri, G | 1 |
| Lombardi, C | 1 |
| Mezzelani, P | 1 |
| Tharp, MD | 1 |
| von Schulthess, A | 1 |
| Breneman, DL | 1 |
| Bertrand, B | 1 |
| Eloy, P | 1 |
| Rombeaux, P | 1 |
| Warner, JO | 1 |
| Pacor, ML | 2 |
| Biasi, D | 1 |
| Carletto, A | 1 |
| Corrocher, R | 2 |
| Uchida, M | 1 |
| Nakahara, H | 1 |
| Parsad, D | 1 |
| Pandhi, R | 1 |
| Juneja, A | 1 |
| La Rosa, M | 1 |
| Leonardi, S | 1 |
| Marchese, G | 1 |
| Corrias, A | 1 |
| Barberio, G | 1 |
| Oggiano, N | 1 |
| Grimaldi, I | 1 |
| Di Lorenzo, G | 1 |
| Schröter, S | 1 |
| Damveld, B | 1 |
| Marsch, WC | 1 |
| Siergiejko, Z | 1 |
| Michalska, I | 1 |
| Rogalewska, A | 1 |
| Chyrek-Borowska, S | 1 |
| Goh, CL | 1 |
| Wong, WK | 1 |
| Lim, J | 1 |
| Townley, RG | 1 |
| Juhlin, L | 2 |
| Rihoux, JP | 2 |
| Kietzmann, H | 1 |
| Macher, E | 1 |
| Ghys, L | 1 |
| Campoli-Richards, DM | 1 |
| Buckley, MM | 1 |
| Fitton, A | 1 |
| Billardon, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment[NCT01371877] | 42 participants (Actual) | Interventional | 2011-11-01 | Completed | |||
| Double-blind, Randomised, Placebo-controlled, Phase III Study Comparing the Efficacy and Safety of Bilastine 20 mg Once Daily and Levocetirizine 5 mg for the Treatment of Chronic Idiopathic Urticaria[NCT00421109] | Phase 3 | 522 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| A Multicentre, International, Adaptive, Open-label, Repeated Administration Pharmacokinetic Study of Bilastine in Children From 2 to <12 Years of Age With Allergic Rhinoconjunctivitis or Chronic Urticaria[NCT01081574] | Phase 1/Phase 2 | 36 participants (Actual) | Interventional | 2010-01-31 | Completed | ||
| Efficacy and Safety of 20 mg Levocetirizine and 15 mg Levocetirizine + 50 mg Bed-Time Hydroxyzine in Severe Chronic Urticaria in Adults: a Pilot, Randomized, Double-blind, Cross-over and Parallel, Active-controlled, Single-centre Study[NCT01250652] | Phase 4 | 24 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Unit of Measure is Safety and Tolerability. The number of participants with adverse events will be compared between the groups using the independent sample t-test (assuming the distribution is normal). (NCT01371877)
Timeframe: 3 month study trial
| Intervention | participants (Number) |
|---|---|
| High Dose Vitamin D | 0 |
| Low Dose Vitamin D | 0 |
The Unit of Measure is Efficacy. The primary outcome of this study is to determine if vitamin D supplementation reduces the medication usage in subjects with CUA. Thus, for the outcome of reduction in pills, at 12 weeks, subjects whose pill usage decreases by 2 or more pills per day will be classified as improved. Subjects whose pill consumption did not change or increased will be classified as unchanged. (NCT01371877)
Timeframe: 12 week intervention
| Intervention | number of pills/day (Mean) | |
|---|---|---|
| Baseline medication usage | 3 month medication usage | |
| High Dose Vitamin D | 2.8 | 2.0 |
| Low Dose Vitamin D | 4.6 | 4.9 |
The Unit of Measure is Efficacy. The Total Urticaria Severity Score (USS) ranges from 0 to 93, higher scores = worse symptoms. This secondary outcome of this study is to determine if high dose vitamin D supplementation improves the urticaria severity score (USS). The change in USS will be compared between the groups using the independent sample t-test (assuming the distribution is normal). Logistic regression and multiple linear regression will be used to adjust for possible confounders. (NCT01371877)
Timeframe: 3 month intervention
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Baseline Total Urticaria Score | 1 week Total Urticaria Score | 3 month Total Urticaria Score | |
| High Dose Vitamin D | 41.14 | 25.48 | 15.0 |
| Low Dose Vitamin D | 40.1 | 29.24 | 24.1 |
8 reviews available for cetirizine and Chronic Illness
| Article | Year |
|---|---|
Levocetirizine for chronic idiopathic urticaria: a review.
Topics: Cetirizine; Chronic Disease; Cost-Benefit Analysis; Histamine H1 Antagonists, Non-Sedating; Humans; | 2009 |
Pharmacokinetic evaluation of levocetirizine.
Topics: Cetirizine; Chronic Disease; Drug Evaluation; Histamine H1 Antagonists, Non-Sedating; Humans; Random | 2011 |
Clinical studies with cetirizine in allergic rhinitis and chronic urticaria.
Topics: Cetirizine; Chronic Disease; Clinical Trials as Topic; Humans; Rhinitis, Allergic, Perennial; Rhinit | 1995 |
Allergy and sinusitis.
Topics: Allergens; Anti-Allergic Agents; Anti-Inflammatory Agents; Beclomethasone; Blood Proteins; Cetirizin | 1997 |
Early treatment of the atopic child.
Topics: Anti-Allergic Agents; Asthma; Cetirizine; Child, Preschool; Chronic Disease; Clinical Trials as Topi | 1997 |
[Pharmacological and clinical properties of cetirizine hydrochloride].
Topics: Animals; Anti-Allergic Agents; Cetirizine; Chemotaxis; Chronic Disease; Electrocardiography; Eosinop | 2000 |
Cetirizine: a new H1 antagonist with antieosinophilic activity in chronic urticaria.
Topics: Cetirizine; Chronic Disease; Eosinophils; Histamine H1 Antagonists; Humans; Hydroxyzine; Urticaria | 1991 |
Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria.
Topics: Animals; Asthma; Cetirizine; Chronic Disease; Histamine H1 Antagonists; Humans; Hydroxyzine; Pollen; | 1990 |
42 trials available for cetirizine and Chronic Illness
| Article | Year |
|---|---|
Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial.
Topics: Benzimidazoles; Cetirizine; Chronic Disease; Chronic Urticaria; Double-Blind Method; Histamine H1 An | 2020 |
Optimization model research on efficacy in treatment of chronic urticaria by Chinese and Western medicine based on a genetic algorithm.
Topics: Algorithms; Case-Control Studies; Cetirizine; Chronic Disease; Drugs, Chinese Herbal; Humans; Urtica | 2013 |
Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial.
Topics: Adult; Cetirizine; Chronic Disease; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antago | 2014 |
Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
Topics: Adult; Aged; Cetirizine; Chronic Disease; Cross-Over Studies; Double-Blind Method; Drug Administrati | 2014 |
Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study.
Topics: Acetates; Adult; Aged; Cetirizine; Cholecalciferol; Chronic Disease; Cyclopropanes; Dietary Suppleme | 2014 |
Levocetirizine and rupatadine in chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Cetirizine; Child; Chronic Disease; Cyproheptadine; Female; Histamine H1 An | 2015 |
Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study.
Topics: Adult; Aged; Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non | 2015 |
Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial.
Topics: Animals; Cetirizine; Chronic Disease; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Method; F | 2016 |
An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose.
Topics: Adolescent; Adult; Aged; Cetirizine; Chronic Disease; Disorders of Excessive Somnolence; Dose-Respon | 2017 |
[Effect of integrative Chinese and Western medicine in treating chronic urticaria and its impact on interleukin-10 and interleukin-8 in peripheral blood].
Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Drug Therapy, Combination; Drugs, Chinese Herbal; Fe | 2008 |
Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Topics: Acetates; Adolescent; Adult; Aged; Cetirizine; Chronic Disease; Cross-Over Studies; Cyclopropanes; D | 2008 |
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Hu | 2009 |
Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
Topics: Acetates; Adolescent; Adult; Cetirizine; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; | 2009 |
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Area Under Curve; Benzimidazoles; Cetirizine; Chronic Disease; Double-Blind | 2010 |
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Area Under Curve; Benzimidazoles; Cetirizine; Chronic Disease; Double-Blind | 2010 |
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Area Under Curve; Benzimidazoles; Cetirizine; Chronic Disease; Double-Blind | 2010 |
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Area Under Curve; Benzimidazoles; Cetirizine; Chronic Disease; Double-Blind | 2010 |
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Topics: Adult; Aged; Cetirizine; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Fem | 2010 |
Efficacy and safety of modified sequential three-step empirical therapy for chronic cough.
Topics: Adult; Aminophylline; Antitussive Agents; Budesonide; Cetirizine; Chlorpheniramine; Chronic Disease; | 2010 |
Clinical observation on the treatment of chronic urticaria with total glucosides of paeony capsule combined with citirizine.
Topics: Adolescent; Adult; Anti-Allergic Agents; Capsules; Cetirizine; Chronic Disease; Drug Therapy, Combin | 2010 |
A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.
Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Hu | 2010 |
Efficacy of Tripterygium hypoglaucum Hutch in adults with chronic urticaria.
Topics: Adult; Antipruritics; Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagon | 2011 |
Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety.
Topics: Adolescent; Adult; Cetirizine; Child; Chronic Disease; Cyproheptadine; Female; Follow-Up Studies; Hi | 2011 |
Olopatadine versus levocetirizine in chronic urticaria: an observer-blind, randomized, controlled trial of effectiveness and safety.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Cetirizine; Chronic Dise | 2013 |
The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results.
Topics: Adult; Autoantigens; Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagoni | 2004 |
Levocetirizine: the allergist's arsenal grows larger.
Topics: Allergy and Immunology; Cetirizine; Chronic Disease; Clinical Trials, Phase III as Topic; Double-Bli | 2004 |
Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Cetirizine; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; | 2006 |
Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
Topics: Adult; Cetirizine; Chronic Disease; Double-Blind Method; Efficiency; Female; Germany; Histamine H1 A | 2006 |
Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating | 2007 |
Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients.
Topics: Adult; Cetirizine; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; | 2007 |
Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial.
Topics: Administration, Oral; Adult; Antipruritics; Cetirizine; Chemical Warfare Agents; Chronic Disease; Do | 2007 |
Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial.
Topics: Adult; Cetirizine; Chronic Disease; Combined Modality Therapy; Female; Histamine H1 Antagonists, Non | 2008 |
Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria.
Topics: Adolescent; Adult; Aged; Cetirizine; Chronic Disease; Cimetidine; Double-Blind Method; Drug Combinat | 1995 |
[The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis].
Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Drug Therapy, Combination; Female; Humans; Male; Mid | 1994 |
[Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria].
Topics: Adolescent; Adult; Cetirizine; Child; Chronic Disease; Double-Blind Method; Female; Humans; Male; Mi | 1993 |
A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria.
Topics: Adult; Cetirizine; Chronic Disease; Double-Blind Method; Humans; Terfenadine; Urticaria | 1993 |
Cetirizine: a new therapeutic alternative for chronic urticaria.
Topics: Adolescent; Adult; Aged; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Male | 1996 |
Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria.
Topics: Adult; Cetirizine; Chronic Disease; Double-Blind Method; Drug Tolerance; Female; Humans; Hydroxyzine | 1996 |
[The efficacy of cetirizine in the treatment of perennial allergic rhinitis].
Topics: Adult; Anti-Allergic Agents; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; | 1999 |
Stanozolol in chronic urticaria: a double blind, placebo controlled trial.
Topics: Adolescent; Adult; Anabolic Agents; Cetirizine; Chronic Disease; Double-Blind Method; Female; Histam | 2001 |
Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children.
Topics: Anti-Allergic Agents; Cetirizine; Child, Preschool; Chronic Disease; Double-Blind Method; Drug Toler | 2001 |
Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid.
Topics: Acetates; Adolescent; Adult; Aged; Aspirin; Cetirizine; Chronic Disease; Cyclopropanes; Double-Blind | 2001 |
Cetirizine vs placebo in chronic idiopathic urticaria--a double blind randomised cross-over study.
Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonist | 1991 |
Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria.
Topics: Benzhydryl Compounds; Cetirizine; Chronic Disease; Double-Blind Method; Histamine H1 Antagonists; Hu | 1990 |
[Importance of Zyrtec in the treatment of chronic urticaria and allergic rhinopathies apropos of 1168 cases seen by hospital practitioners].
Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Hydroxyzin | 1989 |
24 other studies available for cetirizine and Chronic Illness
| Article | Year |
|---|---|
Effect of bilastine on chronic spontaneous urticaria refractory to levocetrizine: Real world experience in India.
Topics: Benzimidazoles; Cetirizine; Chronic Disease; Chronic Urticaria; Humans; India; Piperidines; Urticari | 2021 |
CRP, D-dimer, fibrinogen and ESR as predictive markers of response to standard doses of levocetirizine in patients with chronic spontaneous urticaria.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cetirizine; Chronic Di | 2017 |
Hydroxychloroquine as a steroid-sparing agent in an infant with chronic urticaria.
Topics: Acetates; Anti-Inflammatory Agents; Antimalarials; Cetirizine; Chronic Disease; Cyclopropanes; Diphe | 2018 |
Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria.
Topics: Adolescent; Adult; Calcitonin Gene-Related Peptide; Cetirizine; Chronic Disease; Female; Histamine H | 2014 |
Evaluation of cetirizine hydrochloride-based therapeutic strategy for chronic urticaria.
Topics: Adult; Aged; Aged, 80 and over; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists, Non-S | 2008 |
Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Cetirizine; Chr | 2010 |
Use of cetirizine in a 23-month-old male causes insomnia.
Topics: Anti-Allergic Agents; Cetirizine; Chronic Disease; Humans; Infant; Male; Otitis Media; Sleep Initiat | 2010 |
Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
Topics: Adult; Anti-Allergic Agents; Attitude of Health Personnel; Cetirizine; Child; Child, Preschool; Chro | 2011 |
Chronic idiopathic urticaria in Taiwan: a clinical study of demographics, aggravating factors, laboratory findings, serum autoreactivity and treatment response.
Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Loratadine | 2011 |
Chronic urticaria and angioedema.
Topics: Angioedema; Cetirizine; Chronic Disease; Histamine H1 Antagonists, Non-Sedating; Humans; Hydroxyzine | 2002 |
Evaluation of the efficacy of antihistamines using human monocyte-derived dendritic cells stimulated with histamine.
Topics: Adolescent; Adult; Antigens, CD; B7-2 Antigen; Cetirizine; Chronic Disease; Cimetidine; Dendritic Ce | 2003 |
Elevated substance P levels in nasal lavage fluids from patients with chronic nonproductive cough and increased cough sensitivity to inhaled capsaicin.
Topics: Administration, Inhalation; Adult; Capsaicin; Case-Control Studies; Cetirizine; Chronic Disease; Cou | 2003 |
Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea.
Topics: Adult; Aged; Cell Count; Cetirizine; Chronic Disease; Colon; Diarrhea; Drug Therapy, Combination; Du | 2006 |
Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses.
Topics: Adult; Aged; Cetirizine; Chronic Disease; Drug Administration Schedule; Female; Histamine H1 Antagon | 2007 |
Cellular adhesion molecules in chronic urticaria: modulation of serum levels occurs during levocetirizine treatment.
Topics: Adolescent; Adult; Aged; Cetirizine; Chronic Disease; E-Selectin; Enzyme-Linked Immunosorbent Assay; | 2006 |
Cost effectiveness of levocetirizine in chronic idiopathic urticaria : a pooled analysis of two randomised controlled trials.
Topics: Adult; Anti-Allergic Agents; Cetirizine; Chronic Disease; Cost-Benefit Analysis; Female; Health Care | 2006 |
Acute episode or chronic problem?
Topics: Acute Disease; Angioedema; Cellulitis; Cetirizine; Chronic Disease; Dermatitis, Contact; Diagnosis, | 2007 |
New hay fever, hives treatment approved.
Topics: Cetirizine; Chronic Disease; Clinical Trials as Topic; Histamine H1 Antagonists, Non-Sedating; Human | 2007 |
[Delayed-type pressure urticaria].
Topics: Adult; Angioedema; Anti-Allergic Agents; Cetirizine; Chronic Disease; Humans; Male; Urticaria | 1995 |
Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
Topics: Cetirizine; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Histamine Antagonists; Human | 1999 |
Urticarial intolerance reaction to cetirizine.
Topics: Acute Disease; Adult; Anti-Allergic Agents; Cetirizine; Chronic Disease; Drug Eruptions; Female; His | 2002 |
[Effect of cetirizine, selective H1 antagonist of histamine on skin and bronchial reactivity and cellular histamine release in allergic diseases].
Topics: Asthma; Bronchial Provocation Tests; Cetirizine; Chronic Disease; Histamine; Humans; Neutrophils; Rh | 1992 |
Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria.
Topics: Adult; Blood Transfusion, Autologous; Cetirizine; Chronic Disease; Female; Histamine; Histamine H1 A | 1990 |
Late-phase cutaneous reactions to platelet activating factor and kallikrein in urticaria.
Topics: Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersens | 1990 |